| RS1277939762 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS1277942930 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1277958075 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS1277965530 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1277966688 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Sialic acid storage disease, severe infantile type |
| RS1277968524 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS1277990552 |
DNAJC12
|
Health Risk |
Pathogenic |
Hyperphenylalaninemia due to DNAJC12 deficiency, Hyperphenylalaninemia due to DNAJC12 deficiency |
| RS1277996676 |
OTOGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 84B, Autosomal recessive nonsyndromic hearing loss 84B |
| RS1278005040 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1278019392 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1278021176 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1278022127 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1278026061 |
USH1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 18A, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1278030644 |
RET
|
Health Risk |
Pathogenic |
RET-related disorder, RET-related disorder |
| RS1278038759 |
IMPG1
|
Health Risk |
Likely pathogenic |
— |
| RS1278044377 |
ABCA3
|
Health Risk |
Pathogenic |
— |
| RS1278045166 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1278049478 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1278053918 |
RP1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 1, Retinitis pigmentosa 1 |
| RS12780580 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS1278070199 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1278076805 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1278078294 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1278089386 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis 4, Senior-Loken syndrome 4 |
| RS1278095773 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1278117182 |
B3GALT6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylodysplastic type |
| RS1278119822 |
MFSD2A
|
Health Risk |
Pathogenic |
Microcephaly 15, primary |
| RS1278121916 |
RTEL1
|
Health Risk |
Pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1278137915 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 37, Enhanced S-cone syndrome |
| RS1278139327 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1278142628 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1278147369 |
CREBBP
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1278163109 |
HBG2
|
Health Risk |
Pathogenic |
Cyanosis, transient neonatal |
| RS1278213544 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1278216949 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1278226911 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 26 |
| RS1278227329 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1278228854 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS1278232284 |
INS
|
Health Risk |
Likely pathogenic |
Neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS1278235097 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS1278244243 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, progressive familial intrahepatic |
| RS1278246029 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1278248464 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1278265933 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1278279828 |
NEU1
|
Health Risk |
Pathogenic |
— |
| RS1278300199 |
MN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1278305591 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS1278313953 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1278340100 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1278342620 |
METTL23
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 44 |
| RS1278362025 |
SLC25A46
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1278381406 |
CPS1
|
Health Risk |
Pathogenic |
Pulmonary hypertension, neonatal |
| RS1278390159 |
ACE
|
Health Risk |
Likely pathogenic |
ACE-related disorder, ACE-related disorder |
| RS1278404579 |
PDSS1
|
Health Risk |
Pathogenic |
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome, Deafness-encephaloneuropathy-obesity-valvulopathy syndrome |
| RS1278413331 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS1278460471 |
BBS10
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS1278463714 |
CLCNKB
|
Health Risk |
Pathogenic |
— |
| RS1278468610 |
BTG4
|
Health Risk |
Pathogenic |
Oocyte maturation defect 8, Oocyte maturation defect 8 |
| RS1278475785 |
SLC40A1
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1278487078 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1278493215 |
BCL11B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1278501001 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1278503244 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1278511367 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Naxos disease |
| RS1278514080 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1278522566 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS1278540627 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1278585545 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS1278589861 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS1278597997 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1278603247 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS1278606677 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS1278614167 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1278614363 |
CARMIL2
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARMIL2 deficiency, Severe combined immunodeficiency due to CARMIL2 deficiency |
| RS1278648561 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1278657493 |
MYO3A
|
Health Risk |
Likely pathogenic |
— |
| RS1278679056 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1278689263 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS12786957 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1278698690 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1278701043 |
UNC13D
|
Health Risk |
Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1278702432 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1278715599 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1278743247 |
LAMB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1278743459 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1278744613 |
EIF2B1
|
Health Risk |
Pathogenic |
— |
| RS1278777268 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1278779161 |
ZBTB11
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 69 |
| RS1278785558 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1278804341 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1278804520 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, RYR1-related disorder |
| RS1278815943 |
TSPAN12
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS1278821174 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1278823424 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1278834014 |
SDHB
|
Health Risk |
Likely pathogenic |
Hereditary pheochromocytoma and paraganglioma, Gastrointestinal stromal tumor |
| RS1278834481 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome 1 |
| RS1278836130 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1278843875 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1278858560 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS1278864604 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |